ArticleInfectious diseases and therapy2026
Respiratory Syncytial Virus Immunization Strategies for Older Adults in Gulf Cooperation Council Countries: Expert Consensus and Recommendations.
Article in Infectious diseases and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionRespiratory syncytial virus (RSV) poses a significant health risk to older adults, particularly those with chronic comorbidities, in the Gulf Cooperation Council (GCC) countries. Despite its high burden, RSV remains underrecognized among older adults in this region. This manuscript aims to highlight the burden of RSV among older adults in GCC countries and provide expert consensus recommendations for the implementation of targeted prevention measures, including vaccination strategies.
methodsA multidisciplinary panel of experts from GCC countries reviewed international, regional, and country-level data on RSV. The panel formulated recommendations on the basis of a comprehensive literature review and expert consensus, focusing on the integration of RSV vaccination into routine immunization programs for older adults.
resultsOlder adults, especially those with chronic conditions including but not limited to cardiovascular disease, chronic kidney disease, chronic lung disease, and diabetes, are at an increased risk for severe RSV-related outcomes. Effective vaccines present an opportunity to significantly reduce the incidence and severity of RSV in this vulnerable population. Key recommendations for safeguarding older adults in GCC countries include implementing clear immunization schedules for adults at a country-level that include targeted RSV vaccination, especially among high-risk groups. Providing continuous education for healthcare professionals, increasing vaccine availability, equity, and affordability, conducting public awareness campaigns, and strengthening local surveillance systems also play a crucial role in addressing vaccine-preventable diseases such as RSV.
conclusionsIntegrating RSV vaccination into routine immunization schedules, alongside other key vaccines, is essential for achieving comprehensive and optimal protection for older adults in GCC countries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.